136 related articles for article (PubMed ID: 16303303)
1. Conformation stability and organization of mefloquine molecules in different environments.
Skórska A; Sliwiński J; Oleksyn BJ
Bioorg Med Chem Lett; 2006 Feb; 16(4):850-3. PubMed ID: 16303303
[TBL] [Abstract][Full Text] [Related]
2. Conformation of epicinchonine and cinchonine in view of their antimalarial activity: x-ray and theoretical studies.
Kowalik JT; Lipińska T; Oleksyn BJ; Sliwiński J
Enantiomer; 1999; 4(5):389-410. PubMed ID: 10644163
[TBL] [Abstract][Full Text] [Related]
3. Crystal and molecular structures of trichloro-cobalt(II) complexes of epiquinine, epiquinidine, and epidihydrocinchonine.
Tesarowicz I; Oleksyn BJ; Nitek W
Chirality; 2007 Feb; 19(2):152-61. PubMed ID: 17152047
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure and molecular structure of mefloquine methylsulfonate monohydrate: implications for a malaria receptor.
Karle JM; Karle IL
Antimicrob Agents Chemother; 1991 Nov; 35(11):2238-45. PubMed ID: 1803997
[TBL] [Abstract][Full Text] [Related]
5. Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution.
Gildenhuys J; Sammy CJ; Müller R; Streltsov VA; le Roex T; Kuter D; de Villiers KA
Dalton Trans; 2015 Oct; 44(38):16767-77. PubMed ID: 26335948
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of (-)-mefloquine hydrochloride reveals consistency of configuration with biological activity.
Karle JM; Karle IL
Antimicrob Agents Chemother; 2002 May; 46(5):1529-34. PubMed ID: 11959592
[TBL] [Abstract][Full Text] [Related]
7. Iron(III) protoporphyrin IX complexes of the antimalarial Cinchona alkaloids quinine and quinidine.
de Villiers KA; Gildenhuys J; le Roex T
ACS Chem Biol; 2012 Apr; 7(4):666-71. PubMed ID: 22276975
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of quinine: the effects of vinyl and methoxy groups on molecular assemblies of Cinchona alkaloids cannot be ignored.
Hisaki I; Hiraishi E; Sasaki T; Orita H; Tsuzuki S; Tohnai N; Miyata M
Chem Asian J; 2012 Nov; 7(11):2607-14. PubMed ID: 22915374
[TBL] [Abstract][Full Text] [Related]
9. Determining the absolute configuration of (+)-mefloquine HCl, the side-effect-reducing enantiomer of the antimalaria drug Lariam.
Schmidt M; Sun H; Rogne P; Scriba GK; Griesinger C; Kuhn LT; Reinscheid UM
J Am Chem Soc; 2012 Feb; 134(6):3080-3. PubMed ID: 22148194
[TBL] [Abstract][Full Text] [Related]
10. Interaction studies of omeprazole with mefloquine, pyrimethamine and sulfadoxine.
Arayne MS; Sultana N; Qureshi MS; Naseem S
Pak J Pharm Sci; 2006 Oct; 19(4):314-21. PubMed ID: 17105711
[TBL] [Abstract][Full Text] [Related]
11. Quantum pharmacological analysis of structure-activity relationships for mefloquine antimalarial drugs using optimal transformations.
Nguyen-Cong V; Rode BM
J Chem Inf Comput Sci; 1996; 36(1):114-7. PubMed ID: 8576287
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological activity and structure-activity relationship of (+/-)-erythro-mefloquine and related compounds on the isolated mouse phrenic nerve diaphragm preparation.
Go ML; Lee HS; Ngiam TL
Biol Pharm Bull; 1993 Jul; 16(7):668-74. PubMed ID: 8401399
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine.
Slabbert C; Plessis LH; Kotzé AF
Int J Pharm; 2011 May; 409(1-2):209-15. PubMed ID: 21310223
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.
Shete AS; Yadav AV; Murthy MS
Drug Dev Ind Pharm; 2013 May; 39(5):716-23. PubMed ID: 22639963
[TBL] [Abstract][Full Text] [Related]
15. A Concise and Highly Enantioselective Total Synthesis of (+)-anti- and (-)-syn-Mefloquine Hydrochloride: Definitive Absolute Stereochemical Assignment of the Mefloquines.
Rastelli EJ; Coltart DM
Angew Chem Int Ed Engl; 2015 Nov; 54(47):14070-4. PubMed ID: 26422780
[TBL] [Abstract][Full Text] [Related]
16. A combined NMR, DFT, and X-ray investigation of some cinchona alkaloid O-ethers.
Busygin I; Nieminen V; Taskinen A; Sinkkonen J; Toukoniitty E; Sillanpää R; Murzin DY; Leino R
J Org Chem; 2008 Sep; 73(17):6559-69. PubMed ID: 18683975
[TBL] [Abstract][Full Text] [Related]
17. Crystal and molecular structures of new enantiopure quinuclidines.
Kania I; Stadnicka K; Oleksyn BJ
Chirality; 2004 Mar; 16(3):180-9. PubMed ID: 14770415
[TBL] [Abstract][Full Text] [Related]
18. Conformation analysis of aspartame-based sweeteners by NMR spectroscopy, molecular dynamics simulations, and X-ray diffraction studies.
De Capua A; Goodman M; Amino Y; Saviano M; Benedetti E
Chembiochem; 2006 Feb; 7(2):377-87. PubMed ID: 16372303
[TBL] [Abstract][Full Text] [Related]
19. Quantum-chemical, NMR and X-ray diffraction studies on (+/-)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane.
Zapata-Torres G; Cassels BK; Parra-Mouchet J; Mascarenhas YP; Ellena J; De Araujo AS
J Mol Graph Model; 2008 Jun; 26(8):1296-305. PubMed ID: 18280190
[TBL] [Abstract][Full Text] [Related]
20. The interaction of mefloquine hydrochloride with cell membrane models at the air-water interface is modulated by the monolayer lipid composition.
Goto TE; Caseli L
J Colloid Interface Sci; 2014 Oct; 431():24-30. PubMed ID: 24980622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
